← Eichor
Study identifier: NCT06068322 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease

Condition: COPD · Healthy Controls  ·  Sponsor: Umeå University

PhaseNA
Planned participants208
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersYes

About this study

Beyond pulmonary complications, COPD presents with extrapulmonary manifestations including reduced cognitive, cardiovascular, and muscle function. While exercise training is the cornerstone in the non-pharmacological treatment of COPD, there is a need for new exercise training methods. The COPD-HIIT trial intend to investigate the effects and mechanisms of 12 weeks supramaximal high-intensity interval-training (HIIT) compared to moderate intensive continous training (MICT) in people with COPD and matched healthy controls on important clinical outcomes. The trial also intends to compare the effects of 24 months of exercise training (supramaximal HIIT or MICT) to usual care in people with COPD on brain health, cardiorespiratory fitness and muscle power; in people with COPD.

This description comes directly from the study's public registry record.

Talk to the study team

André Nyberg, PhD  ·  +46 090-786 66 39  ·  andre.nyberg@umu.se

Johan Jakobsson, M.Sc.  ·  +46 090 786 63 73  ·  johan.jakobsson@umu.se

Always discuss trial participation with your own doctor first.

Locations (2)

Hasselt UniversityHasselt, Diepenbeek, BelgiumRecruiting
Umeå UniversityUmeå, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06068322